194-199
Coronavirus disease 2019 (COVID-19), MERS and SARS: Similarity and difference
Authors: Zeinab Mohseni Afshar1 , Soheil Ebrahimpour2 , Mostafa Javanian2 , Veerendra Koppolu3 , Veneela Krishna Rekha Vasigala4 , Amir Hossein Hasanpour5 , Arefeh Babazadeh2
Number of views: 207
SARS-CoV-2 is the causative agent of COVID-19. Since its
outbreak in December 2019, COVID-19 has swept the globe.
By 17 July 2020, the World Health Organization (WHO) had
confirmed 13 119 239 cases and 573 752 deaths, and the numbers
are still rising. Current evidence shows that COVID-19 is
lower than severe acute respiratory syndrome and Middle East
respiratory syndrome in terms of severity and mortality risk,
although the infections are particularly more severe in patients
with underlying medical conditions. The bulk of COVID-19
patients had close contact with confirmed cases, but an exact origin
and specific transmission for COVID-19 are still unknown. As
there is no approved antiviral treatment for COVID-19 infection,
proper prevention and control practices are essential to control the
infection. To have an insight view of COVID-19, we summarized
and compared the etiology, clinical manifestations, diagnosis,
treatment, and prevention measures of COVID-19, severe acute
respiratory syndrome, and Middle East respiratory syndrome.